Tsuyoshi Hirose

This inventor holds 17 USPTO granted patents and 4 published patent applications, plus 5 CIPO patents and 3 EPO patents, primarily in Mood Disorders Treatment. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 1996-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tsuyoshi Hirose. Retrieved from https://idiyas.com/inventor/tsuyoshi-hirose

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 4)

% Patents Active = 41.2

CIPO Patents = 5

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 4.2

ph-index = 4

Forward Citations = 119(Granted Patents)

Location History:

Kagawa, JP (1996)
Tokushima, JP (1999 - 2017)

Company Filing History:

17 out of 846

Otsuka Pharmaceutical Company, Limited

patents

Years Active: 1996-2017

Loading Chart...

Areas of Expertise:

Carbostyril Derivatives

Serotonin Reuptake Inhibitors

5-HT1A Receptor Agonist

Mood Stabilizers

Cognitive Impairments

Neurodegenerative Diseases

Schizophrenia

Autism

Panic Disorder

ADHD

Diagnostic Methods

Benzylamine Derivatives

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9694009 - Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders (2017-07-04),

2. 9387207 - 5-HT1A receptor subtype agonist (2016-07-12),

3. 9387182 - Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders (2016-07-12),

4. 9125939 - Carbostyril derivatives and mood stabilizers for treating mood disorders (2015-09-08),

5. 9089567 - Method of treating cognitive impairments and schizophrenias (2015-07-28),

6. 9006248 - [object Object] (2015-04-14),

7. 8759350 - Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders (2014-06-24),

8. 8722680 - Method of treating neurodegenerative diseases (2014-05-13),

9. 8680105 - Method of treating down's syndrome (2014-03-25),

10. 8642600 - Method of treating autism (2014-02-04),

11. 8623874 - Method of treating neurodegenerative diseases (2014-01-07),

12. 8604041 - Method of treating panic disorder (2013-12-10),

13. 8426423 - Method of treating Attention Deficit Hyper-Activity Disorder (2013-04-23),

14. 8030312 - 5-HT1A receptor subtype agonist (2011-10-04),

15. 7053092 - 5-HT1a receptor subtype agonist (2006-05-30),

Title: Tsuyoshi Hirose: Innovator in Pharmaceutical Composition

Introduction

Tsuyoshi Hirose is a prominent inventor based in Tokushima, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for mood disorders. With a total of 17 patents to his name, Hirose's work has had a substantial impact on mental health therapies.

Latest Patents

Hirose's latest patents focus on carbostyril derivatives and serotonin reuptake inhibitors for the treatment of mood disorders. The pharmaceutical composition he developed comprises a carbostyril derivative and a serotonin reuptake inhibitor in a pharmaceutically acceptable carrier. The carbostyril derivative may include aripiprazole or its metabolites, which act as dopamine-serotonin system stabilizers. The serotonin reuptake inhibitors mentioned in his patents include fluoxetine, duloxetine, venlafaxine, milnacipran, citalopram, fluvoxamine, paroxetine, sertraline, and escitalopram. This innovative composition is particularly useful for treating patients with mood disorders, especially depression or major depressive disorder.

Career Highlights

Hirose is currently associated with Otsuka Pharmaceutical Company, Limited, where he continues to advance his research and development efforts. His work has been instrumental in creating effective pharmaceutical solutions that address complex mental health issues.

Collaborations

Hirose has collaborated with notable colleagues such as Tetsuro Kikuchi and Katsura Tottori. Their combined expertise has contributed to the success of various projects within the pharmaceutical domain.

Conclusion

Tsuyoshi Hirose's innovative contributions to the field of pharmaceuticals, particularly in mood disorder treatments, highlight his importance as an inventor. His ongoing work at Otsuka Pharmaceutical Company, Limited, and his numerous patents reflect his commitment to improving mental health therapies.

Profile summary based on public USPTO records.